CGEM
Price
$7.67
Change
-$0.10 (-1.29%)
Updated
Aug 1, 04:59 PM (EDT)
Capitalization
452.64M
6 days until earnings call
OCUL
Price
$11.92
Change
+$0.34 (+2.94%)
Updated
Aug 1, 04:59 PM (EDT)
Capitalization
1.9B
3 days until earnings call
Interact to see
Advertisement

CGEM vs OCUL

Header iconCGEM vs OCUL Comparison
Open Charts CGEM vs OCULBanner chart's image
Cullinan Therapeutics
Price$7.67
Change-$0.10 (-1.29%)
Volume$2.55K
Capitalization452.64M
Ocular Therapeutix
Price$11.92
Change+$0.34 (+2.94%)
Volume$167.85K
Capitalization1.9B
CGEM vs OCUL Comparison Chart in %
Loading...
CGEM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OCUL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CGEM vs. OCUL commentary
Aug 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGEM is a Hold and OCUL is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 02, 2025
Stock price -- (CGEM: $7.76 vs. OCUL: $11.56)
Brand notoriety: CGEM and OCUL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGEM: 71% vs. OCUL: 59%
Market capitalization -- CGEM: $481.56M vs. OCUL: $1.9B
CGEM [@Biotechnology] is valued at $481.56M. OCUL’s [@Biotechnology] market capitalization is $1.9B. The market cap for tickers in the [@Biotechnology] industry ranges from $223.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGEM’s FA Score shows that 1 FA rating(s) are green whileOCUL’s FA Score has 0 green FA rating(s).

  • CGEM’s FA Score: 1 green, 4 red.
  • OCUL’s FA Score: 0 green, 5 red.
According to our system of comparison, CGEM is a better buy in the long-term than OCUL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGEM’s TA Score shows that 3 TA indicator(s) are bullish while OCUL’s TA Score has 3 bullish TA indicator(s).

  • CGEM’s TA Score: 3 bullish, 5 bearish.
  • OCUL’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both CGEM and OCUL are a bad buy in the short-term.

Price Growth

CGEM (@Biotechnology) experienced а -6.84% price change this week, while OCUL (@Biotechnology) price change was -3.02% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.32%. For the same industry, the average monthly price growth was +16.82%, and the average quarterly price growth was +37.20%.

Reported Earning Dates

CGEM is expected to report earnings on Nov 06, 2025.

OCUL is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Biotechnology (+1.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OCUL($1.9B) has a higher market cap than CGEM($453M). OCUL YTD gains are higher at: 35.363 vs. CGEM (-36.289). OCUL has higher annual earnings (EBITDA): -176.35M vs. CGEM (-208.62M). OCUL has more cash in the bank: 350M vs. CGEM (304M). CGEM has less debt than OCUL: CGEM (1.84M) vs OCUL (76.2M). OCUL has higher revenues than CGEM: OCUL (59.6M) vs CGEM (0).
CGEMOCULCGEM / OCUL
Capitalization453M1.9B24%
EBITDA-208.62M-176.35M118%
Gain YTD-36.28935.363-103%
P/E RatioN/AN/A-
Revenue059.6M-
Total Cash304M350M87%
Total Debt1.84M76.2M2%
FUNDAMENTALS RATINGS
OCUL: Fundamental Ratings
OCUL
OUTLOOK RATING
1..100
76
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
PROFIT vs RISK RATING
1..100
82
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CGEMOCUL
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
80%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 4 days ago
73%
Bullish Trend 10 days ago
80%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
76%
Aroon
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CGEM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OCUL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BFTUX66.010.19
+0.29%
Baron Fifth Avenue Growth R6
FTHAX46.12N/A
N/A
FullerThaler Behavioral Sm-Cp Eq A
BGFRX13.58N/A
N/A
William Blair Growth R6
FPKFX16.84N/A
N/A
Fidelity Puritan K6
JEUIX17.61N/A
N/A
Janus Henderson Global Sust Eq I

CGEM and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGEM has been loosely correlated with IDYA. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if CGEM jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGEM
1D Price
Change %
CGEM100%
-4.90%
IDYA - CGEM
52%
Loosely correlated
-3.94%
ATXS - CGEM
50%
Loosely correlated
+2.82%
DNLI - CGEM
48%
Loosely correlated
+1.17%
EYPT - CGEM
48%
Loosely correlated
-0.20%
OCUL - CGEM
46%
Loosely correlated
-0.86%
More